title: Moderate influenza vaccine effectiveness in Victoria, Australia, 2011.
abstract: We used a sentinel general practitioner (GP) network to conduct surveillance for laboratory-confirmed influenza amongst patients presenting with influenza-like illness (ILI) in Victoria, Australia in 2011. The test negative variation of the case control study design was used to estimate effectiveness for seasonal trivalent influenza vaccine. Cases and controls were ILI patients that tested positive and negative for influenza, respectively. Vaccination status was recorded by GPs and vaccine effectiveness (VE) was calculated as (1-adjusted odds ratio)x100%. There were 529 patients included in the study, of which 29% were influenza positive. Twelve percent of study participants were reported as vaccinated, 6% of cases and 15% of controls. Adjusted VE against all influenza was 56%, but not statistically significant. There was generally little variation in VE estimates when stratified by virus type and subtype, which is consistent with good matches between circulating strains and the vaccine strains. The VE was higher among adults of working age than among children.
authors.affiliation: Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia. james.fielding@mh.org.au
authors.forename: J E
authors.initials: JE
authors.lastname: Fielding
authors.forename: K A
authors.initials: KA
authors.lastname: Grant
authors.forename: T
authors.initials: T
authors.lastname: Tran
authors.forename: H A
authors.initials: HA
authors.lastname: Kelly
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001315:Australia / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks / Q000517:prevention & control* / Q000706:statistics & numerical data*; D005260:Female; D058006:General Practice / Q000706:statistics & numerical data*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007252:Influenza Vaccines / Q000627:therapeutic use*; D007251:Influenza, Human / Q000453:epidemiology* / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D011159:Population Surveillance / Q000379:methods*; D016896:Treatment Outcome; D014505:Urban Population / Q000706:statistics & numerical data; D055815:Young Adult
chemical_list: D007252:Influenza Vaccines